176 related articles for article (PubMed ID: 25409543)
1. Different inhibitory effect and mechanism of hydroxyapatite nanoparticles on normal cells and cancer cells in vitro and in vivo.
Han Y; Li S; Cao X; Yuan L; Wang Y; Yin Y; Qiu T; Dai H; Wang X
Sci Rep; 2014 Nov; 4():7134. PubMed ID: 25409543
[TBL] [Abstract][Full Text] [Related]
2. Synergism of hydroxyapatite nanoparticles and recombinant mutant human tumour necrosis factor-alpha in chemotherapy of multidrug-resistant hepatocellular carcinoma.
Li G; Dong S; Qu J; Sun Z; Huang Z; Ye L; Liang H; Ai X; Zhang W; Chen X
Liver Int; 2010 Apr; 30(4):585-92. PubMed ID: 19780956
[TBL] [Abstract][Full Text] [Related]
3. Effect of hydroxyapatite nanoparticles on the ultrastructure and function of hepatocellular carcinoma cells in vitro.
Yin MZ; Han YC; Bauer IW; Chen P; Li SP
Biomed Mater; 2006 Mar; 1(1):38-41. PubMed ID: 18458384
[TBL] [Abstract][Full Text] [Related]
4. Selenium-substituted hydroxyapatite nanoparticles and their in vivo antitumor effect on hepatocellular carcinoma.
Yanhua W; Hao H; Li Y; Zhang S
Colloids Surf B Biointerfaces; 2016 Apr; 140():297-306. PubMed ID: 26764116
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo anticancer activity evaluation of ursolic acid derivatives.
Shao JW; Dai YC; Xue JP; Wang JC; Lin FP; Guo YH
Eur J Med Chem; 2011 Jul; 46(7):2652-61. PubMed ID: 21514015
[TBL] [Abstract][Full Text] [Related]
6. SC-III3, a novel scopoletin derivative, induces cytotoxicity in hepatocellular cancer cells through oxidative DNA damage and ataxia telangiectasia-mutated nuclear protein kinase activation.
Zhao P; Chen L; Li LH; Wei ZF; Tong B; Jia YG; Kong LY; Xia YF; Dai Y
BMC Cancer; 2014 Dec; 14():987. PubMed ID: 25527123
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo mechanism of hepatocellular carcinoma inhibition by β-TCP nanoparticles.
Liu L; Dai H; Wu Y; Li B; Yi J; Xu C; Wu X
Int J Nanomedicine; 2019; 14():3491-3502. PubMed ID: 31190806
[No Abstract] [Full Text] [Related]
8. Effect of Hydroxyapatite Nanoparticles on the Growth Potential of Hepatoma Cells in Nude Mice.
Yin M; Yin Y; Chen H; Han Y; Dai H; Li S
J Nanosci Nanotechnol; 2015 May; 15(5):3816-22. PubMed ID: 26505010
[TBL] [Abstract][Full Text] [Related]
9. Effects of four types of hydroxyapatite nanoparticles with different nanocrystal morphologies and sizes on apoptosis in rat osteoblasts.
Xu Z; Liu C; Wei J; Sun J
J Appl Toxicol; 2012 Jun; 32(6):429-35. PubMed ID: 22162110
[TBL] [Abstract][Full Text] [Related]
10. Antitumoural hydroxyapatite nanoparticles-mediated hepatoma-targeted trans-arterial embolization gene therapy: in vitro and in vivo studies.
Li G; Ye L; Pan J; Long M; Zhao Z; Yang H; Tian J; Wen Y; Dong S; Guan J; Luo B
Liver Int; 2012 Jul; 32(6):998-1007. PubMed ID: 22340582
[TBL] [Abstract][Full Text] [Related]
11. Enhanced antitumor efficacy, biodistribution and penetration of docetaxel-loaded biodegradable nanoparticles.
Liu Q; Li R; Zhu Z; Qian X; Guan W; Yu L; Yang M; Jiang X; Liu B
Int J Pharm; 2012 Jul; 430(1-2):350-8. PubMed ID: 22525076
[TBL] [Abstract][Full Text] [Related]
12. Characterization of natural hydroxyapatite originated from fish bone and its biocompatibility with osteoblasts.
Shi P; Liu M; Fan F; Yu C; Lu W; Du M
Mater Sci Eng C Mater Biol Appl; 2018 Sep; 90():706-712. PubMed ID: 29853142
[TBL] [Abstract][Full Text] [Related]
13. Negative-charge-functionalized mesoporous silica nanoparticles as drug vehicles targeting hepatocellular carcinoma.
Xie M; Xu Y; Shen H; Shen S; Ge Y; Xie J
Int J Pharm; 2014 Oct; 474(1-2):223-31. PubMed ID: 25149125
[TBL] [Abstract][Full Text] [Related]
14. Chloroquine inhibits hepatocellular carcinoma cell growth in vitro and in vivo.
Hu T; Li P; Luo Z; Chen X; Zhang J; Wang C; Chen P; Dong Z
Oncol Rep; 2016 Jan; 35(1):43-9. PubMed ID: 26530158
[TBL] [Abstract][Full Text] [Related]
15. Total alkaloids of Rubus aleaefolius Poir inhibit hepatocellular carcinoma growth in vivo and in vitro via activation of mitochondrial-dependent apoptosis.
Zhao J; Chen X; Lin W; Wu G; Zhuang Q; Zhong X; Hong Z; Peng J
Int J Oncol; 2013 Mar; 42(3):971-8. PubMed ID: 23338043
[TBL] [Abstract][Full Text] [Related]
16. A molecular receptor targeted, hydroxyapatite nanocrystal based multi-modal contrast agent.
Ashokan A; Menon D; Nair S; Koyakutty M
Biomaterials; 2010 Mar; 31(9):2606-16. PubMed ID: 20035998
[TBL] [Abstract][Full Text] [Related]
17. Synthetic cannabinoid quinones: preparation, in vitro antiproliferative effects and in vivo prostate antitumor activity.
Morales P; Vara D; Goméz-Cañas M; Zúñiga MC; Olea-Azar C; Goya P; Fernández-Ruiz J; Díaz-Laviada I; Jagerovic N
Eur J Med Chem; 2013; 70():111-9. PubMed ID: 24141201
[TBL] [Abstract][Full Text] [Related]
18. Molecular mechanism of hepatocellular carcinoma-specific antitumor activity of the novel thienopyridine derivative TP58.
Zhou R; Huang WJ; Guo ZY; Li L; Zeng XR; Deng YQ; Hu FY; Tong AP; Yang L; Yang JL
Oncol Rep; 2012 Jul; 28(1):225-31. PubMed ID: 22552608
[TBL] [Abstract][Full Text] [Related]
19. Ethyl pyruvate inhibits proliferation and induces apoptosis of hepatocellular carcinoma via regulation of the HMGB1-RAGE and AKT pathways.
Cheng P; Dai W; Wang F; Lu J; Shen M; Chen K; Li J; Zhang Y; Wang C; Yang J; Zhu R; Zhang H; Zheng Y; Guo CY; Xu L
Biochem Biophys Res Commun; 2014 Jan; 443(4):1162-8. PubMed ID: 24361892
[TBL] [Abstract][Full Text] [Related]
20. Total alkaloids of Rubus aleaefolius Poir. inhibit the STAT3 signaling pathway leading to suppression of proliferation and cell cycle arrest in a mouse model of hepatocellular carcinoma.
Zhao J; Lin W; Cao Z; Liu L; Zhuang Q; Zhong X; Hong Z; Peng J
Oncol Rep; 2013 Sep; 30(3):1309-14. PubMed ID: 23828071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
